Saturday 17 October 2026 Export NRIX’s income statement to Excel — free account

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.’s revenue for fiscal 2025 (year ended November 2025) was $84.0 million, up 54.0% from fiscal 2024. In the quarter to August 2026, revenue grew 8,426.3%, EPS grew 578.5% and free cash flow grew 1,122.1%, each against the same quarter a year earlier.

24.42 0.53 −2.12%

Follow NRIX

Alert me

Market cap: $2.7B
P/E: 9.7×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 4/9
Altman Z: 3.77
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Nov '25	Feb '26	May '26	Aug '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	2	2	7
ROE Full definition →		(49.63%)	(61.40%)	(80.30%)	43.99%
ROA Full definition →		(38.96%)	(47.20%)	(60.57%)	34.33%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(48.72%)	(61.02%)	(84.40%)	29.71%
Average Days of Receivables Full definition →		0.00	0.00	0.00	10.40
Free Cash Flow per Share Full definition →		(3.04)	(2.47)	(2.74)	3.31
Free Cash Flow Full definition →		(263.47)	(271.85)	(304.53)	369.81
Capital Expenditures Full definition →		(14.00)	(11.56)	(10.82)	(9.50)
Other line items
Cash ROIC Full definition →		(23.28%)	(26.61%)	(35.99%)	18.34%
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	66.22
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	(0.05)
Research and Development Expense of Revenue Full definition →		377.36%	461.66%	927.31%	47.59%
Selling, General and Administrative Expense of Revenue Full definition →		62.80%	77.60%	155.06%	11.14%
Share Based Compensation of Revenue Full definition →		45.21%	53.84%	107.84%	5.79%
Operating CF/Net income Full definition →		0.94	0.88	0.86	1.29
Depreciation/Fixed assets Full definition →		0.38	0.38	0.35	0.29
Capex/Depreciation Full definition →		(1.64)	(1.41)	(1.56)	(1.71)
Revenue per Share Full definition →		0.97	0.65	0.33	6.29
Operating CF per Share Full definition →		(2.88)	(2.36)	(2.64)	3.40
Capex per Share Full definition →		(0.16)	(0.10)	(0.10)	(0.09)
Capex to Sales Full definition →		0.17	0.16	0.29	0.01

Show all line items

Columns are period end dates · fundamentals updated 15 Oct 2026

Stockrow Weekly